Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion type Assertion NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_head.
- NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion description "[Chronic myelogenous leukemia (CML) cells resistant to the BCR-ABL inhibitor imatinib (IM-R cells) were found to overexpress SPARC mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_provenance.
- NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion evidence source_evidence_literature NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_provenance.
- NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion SIO_000772 21098700 NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_provenance.
- NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion wasDerivedFrom befree-2016 NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_provenance.
- NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_assertion wasGeneratedBy ECO_0000203 NP853954.RAxZjxWG78TD5PvUDXm5y5oS7NhJjj8CW4K3AcmzAzxB0130_provenance.